Marta Fortuny

5PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Characterization of the stages of chronic liver disease based on plasma proteins involved in systemic inflammation.

|Feb 23, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial).

Marco Sanduzzi-Zamparelli, Ana Matilla, José Luis Lledo

|Aug 12, 2025
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.

Marta Fortuny, Leonardo G da Fonseca, Manon Allaire

|Jan 24, 2024
Systemic therapies in hepatocellular carcinoma: A revolution?

Marta Fortuny, Marco Sanduzzi-Zamparelli, Maria Reig

|Oct 18, 2023
Systematic review of the role of calprotectin in cirrhosis.

Marta Fortuny, Maria-Rosa Sarrias, Maria Torner

Pageof 1

Frequent Collaborators

3 joint publications

Marco Sanduzzi-Zamparelli

2 joint publications

Maria Torner

2 joint publications

Alba Ardèvol

2 joint publications

Ramon Bartolí